Who Is The Owner Of Ranbaxy Family? Uncovering The Singh Family Legacy

Let’s dive into the story of the Ranbaxy family and explore who owns the company.

Malvinder Mohan Singh, along with his brother Shivinder Singh, are the grandsons of Bhai Mohan Singh. Bhai Mohan Singh acquired Ranbaxy Laboratories from its original founders in 1952. Parvinder Singh, their father, played a crucial role in the company’s growth and success. Following Parvinder Singh’s passing in 1999, Malvinder and Shivinder inherited a 33.5% stake in Ranbaxy. This inheritance marked the beginning of their leadership journey, where they continued to drive the company forward.

It’s important to understand that while the Singh brothers held a significant stake in Ranbaxy, the company itself was eventually sold to Japanese pharmaceutical giant Daiichi Sankyo in 2008. This transaction represented a major shift in the ownership structure of Ranbaxy. However, the Singh family’s legacy and impact on the pharmaceutical industry are undeniable. Their contributions, particularly during their leadership, played a critical role in establishing Ranbaxy as a prominent name in the global pharmaceutical landscape. While the Singh brothers may no longer be directly involved in running the company, their story is a testament to the dynamism of the Indian pharmaceutical industry and the legacy it carries forward.